• (301) 755-2600 |
  • (301) 754-1200
  • Book Appointment
What Is Central Serous Chorioretinopathy?

Central Serous Chorioretinopathy (CSCR)

Schedule Today

(301) 754-1200
(301) 754-1200 Book Appointment
Rectangle 24
Rectangle 25

What Is Central Serous Chorioretinopathy?

CSCR occurs when fluid collects beneath the retina, creating a blister like elevation that alters normal visual processing. Understanding how and why this fluid develops helps explain the visual changes patients notice.

A defect in the normally water tight layers beneath the retina allows fluid to seep under the macula. This buildup distorts the delicate retinal tissue and disrupts clear central vision.

The condition most often affects men between 30 and 50 years old, although people outside this group can also develop CSCR.

The retina functions like a camera sensor. When fluid lifts the macula, light no longer focuses correctly, resulting in blurred or wavy vision similar to a smudge on a lens.

Signs and Symptoms

Signs and Symptoms

CSCR can present with several hallmark symptoms, yet some patients have few complaints if the fluid spares the very center of the macula.

Affected eyes may not see as sharply as before, and images often appear less vibrant.

Straight lines can look wavy or bent, signaling central macular involvement.

Some individuals notice a small area in the center of vision that appears darker or even missing.

Colors may seem duller or less saturated, making familiar objects look different.

Diagnosis

Diagnosis

Accurate diagnosis relies on specialized testing that reveals the presence and extent of subretinal fluid.

A dye based test highlights retinal blood vessels and pinpoints the exact source of fluid leakage.

This non invasive scan provides high resolution cross sectional images that show even minute amounts of fluid under the macula.

A dilated exam gives a baseline view of the retina and helps guide which additional tests are needed.

Together, the tests create a complete picture of retinal health, confirm CSCR, and rule out other conditions that can mimic its findings.

Risk Factors

The exact cause of CSCR is not fully understood, yet several factors increase the likelihood of developing the condition.

High stress levels and type A personality characteristics raise circulating cortisol, which can weaken the barrier that normally keeps retinal fluid in check.

Corticosteroids and certain other drugs can disturb retinal pigment epithelium function and promote fluid leakage.

  • Oral, topical, inhaled, or injected corticosteroids
  • Phosphodiesterase 5 inhibitors
  • Specific immune suppressing medications

High blood pressure, Cushing syndrome, and other illnesses that alter hormone or vascular balance have been linked to CSCR.

Prognosis and Long Term Outlook

Prognosis and Long Term Outlook

The overall outlook is favorable, yet long term monitoring remains important.

In many cases the leakage stops on its own and fluid reabsorbs, allowing near normal vision to return.

About one quarter of patients experience repeat episodes, and a smaller group eventually develops CSCR in both eyes.

Regular visits enable early detection of new fluid, help protect the outer retina from lasting damage, and guide treatment decisions.

Treatment Approaches

Treatment Approaches

Although some episodes resolve without intervention, persistent or recurrent CSCR may require therapy to safeguard vision.

Acute cases often clear within three months. During this period lifestyle changes such as stress reduction, blood pressure control, and discontinuation of corticosteroids when possible are encouraged.

  • Monitor vision at home
  • Practice relaxation techniques
  • Review medications with your healthcare providers

A light activated dye and low power laser work together to seal leaking vessels. Reduced dose protocols minimize side effects while effectively clearing subretinal fluid.

This laser delivers energy in brief pulses that stimulate healing without harming surrounding tissue, resolving fluid in many chronic cases.

In select situations where abnormal blood vessels accompany CSCR, anti VEGF medicines such as ranibizumab or aflibercept help reduce leakage.

Medications like eplerenone and spironolactone can lower subretinal fluid volumes and improve vision in chronic disease.

By enhancing choroidal blood flow, daily low dose aspirin has been shown to speed visual recovery and lessen recurrence rates in some studies.

Frequently Asked Questions

Frequently Asked Questions

The following questions address common concerns our patients share about CSCR.

Yes. In many instances the condition clears within weeks or months, and more than 90 percent of patients regain good vision.

Monitor for blurred or dim central vision, a dark or gray spot, wavy lines, or noticeable changes in color perception.

High stress, corticosteroid use, certain medications, and systemic conditions such as hypertension or Cushing syndrome can increase risk.

Persistent fluid or recurring episodes may benefit from treatments like photodynamic therapy, micropulse laser, or medication adjustments guided by your retina specialist.

Your Vision, Our Commitment

Your Vision, Our Commitment

Living with CSCR can be challenging, yet most people enjoy excellent outcomes with proper care. Our clinic is committed to providing advanced diagnostics, thoughtful treatment plans, and ongoing support so you can maintain clear, comfortable vision.